跳至主要内容
临床试验/TCTR20210219002
TCTR20210219002尚未招募4 期

Efficacy of 0.28 % Sodium hyaluronate eyedrop in patient with evaporative dry eye in Rajavithi Hospital: randomized double-blind controlled trial.

ational innovation agency, Thailand0 个研究点目标入组 50 人开始时间: 2021年2月19日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Age more than 18 years.
  • Ocular surface disease Index not more than 13
  • Noninvasive tear break up time less than 10 seconds, both eyes.
  • Schirmer 1 test more than 5.5 mm. (in 5 minutes), both eyes.

排除标准

  • Oxford grading scale not more than 4
  • Previous preservative eye drop use in 1 week.
  • Previous ocular surgery in 4 months.
  • History of nasolacrimal duct obstruction.
  • Allergy to sodium hyaluronate.
  • History of other ocular disease for example glaucoma, uveitis.
  • History of contact lenses used.
  • History of use connective tissue disease for example rheumatoid arthritis SLE, Sjogren disease.

研究者

发起方
ational innovation agency, Thailand

相似试验